Download the Agenda


Speakers

Early-confirmed speakers:

  Apexigen
Xiaodong Yang
CEO
Apexigen
  Imperial College
Justin Stebbing
Professor of Cancer Medicine and Medical Oncology
Imperial College
 
Grant Risdon
Head of Corporate Development
Agonox
  iTeos Therapeutics
Christophe Quéva
CSO
iTeos Therapeutics
  MedImmune
Simon Dovedi
Team Leader
MedImmune
  ImmunGene
Michael Gresser
CSO
ImmunGene
  Merck, Sharp & Dohme
Roy Baynes
Senior VP, Global Clinical Development
Merck, Sharp & Dohme
  OncoQR ML
Dr Geert Mudde
Founder and CSO
OncoQR ML
  University of Cambridge
Professor Christopher Rudd
Professor of Molecular Immunology
University of Cambridge
  Pfizer
Cris Kamperschroer
Senior Principal Scientist
Pfizer
  Barts Cancer Institute
Esther Castellano-Sanchez
Cancer and Inflammation Early Career Researcher
Barts Cancer Institute
  Ella Institute of Melanoma Sheba Medical Center
Prof. Gal Markel
Chief Scientist
Ella Institute of Melanoma Sheba Medical Center
  Simomics
Mark Coles
Chief Scientific Officer
Simomics
  Prima BioMed
Frédéric Triebel
CSO and CMO
Prima BioMed

Sponsorship Opportunities

Resource Center

Visit the Resource Center for complimentary industry related content!

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!